Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Alembic Pharma gets USFDA nod for generic drug
Alembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clearance from the USFDA for Lamotrigine orally disintegrating tablets. This drug is therapeutically equivalent to GlaxoSmithKline's Lamictal. It is used for various seizure types in patients aged two and older. The market for this medication is estimated at USD 27 million.
Stocks to Watch Today: Rajputana Stainless, Cosmic CRF, Gaudium IVF, Ahluwalia Contracts, Manappuram, Nazara Tech, GR Infraprojects, Belrise in focus on 19 March
Stocks to Warch, 19 March: Stocks like Gaudium IVF and Women Health, Ahluwalia Contracts, Manappuram Finance, Nazara Technologies, G R Infraprojects, Belrise Industries, Puravankara, Mazagon Dock Shipbuilders, Natco Pharma, United Breweries, and Vedanta will be in focus on March 19.
Stocks to Watch Today: Aurobindo Pharma, Niva Bupa, Brigade, Escorts Kubota, Hero MotoCorp, Hyundai Motor, Tata Motors, Clean Max, Accord Transformer in focus on 2 March
Stocks to Watch, 02 March: Stocks like Maruti Suzuki India, Hyundai Motor India, Hero MotoCorp, Eicher Motors, Tata Motors, Tata Motors Passenger Vehicles, Mahindra and Mahindra, TVS Motor Company, Escorts Kubota, Niva Bupa Health Insurance Company, and Clean Max Enviro Energy Solutions will be in focus on March 2.